Asparagine Metabolism in Cancer Biology

Asparagine is a non-essential amino acid that plays diverse roles beyond protein synthesis in both normal and malignant cells. Its availability is governed by intracellular synthesis through asparagine synthetase (ASNS) and by uptake from extracellular sources, including dietary supply and stromal cell release. In cancer, dysregulation of asparagine metabolism supports tumour growth, survival under nutrient stress, metastatic progression and therapy resistance. Elevated ASNS expression in some cancers underpins resistance to asparaginase-based therapies, whereas in other contexts malignant cells exploit extracellular asparagine via upregulated transporters. Asparagine also acts as an amino acid exchange factor, regulating uptake of key amino acids and sustaining anabolic signalling through mechanistic target of rapamycin complex 1 (mTORC1). Moreover, asparagine depletion or restriction elicits adaptive stress responses mediated by factors such as nuclear factor erythroid 2-related factor 2 (NRF2) and activates cell-intrinsic pathways that reshape metabolism and modulate immune function. Interplay between tumour cells and the microenvironment, including stromal and immune cells, further refines asparagine availability and influences chemosensitivity. Understanding these metabolic networks has highlighted asparagine as a critical node for therapeutic intervention, guiding the optimisation of asparaginase regimens, dietary manipulation and combination strategies targeting metabolic vulnerabilities in cancer.

Research from Nature Portfolio

Recent studies have elucidated the dualistic role of asparagine in tumour biology and immunotherapy. Work in activated CD8+ T cells demonstrated that restricting asparagine supply engages an NRF2-dependent stress programme, enhancing nucleotide synthesis, reducing glucose and glutamine consumption during differentiation, and ultimately boosting antitumour immunity. This finding suggests that controlled asparagine limitation could be harnessed to improve T cell-based therapies. Complementing this, foundational research has established that intracellular asparagine functions as an amino acid exchange factor, exchanging with extracellular essential amino acids to regulate mTORC1 activity, protein synthesis and nucleotide biosynthesis. By maintaining asparagine homeostasis, cancer cells coordinate nutrient uptake and anabolic growth.

Asparagine Metabolism in Cancer Biology publication trend

The graph below shows the total number of articles in asparagine metabolism in cancer biology across all publications each year (not limited to Nature Index journals).

Technical terms

Asparagine synthetase (ASNS): Enzyme that catalyses the ATP-dependent conversion of aspartate and glutamine into asparagine and glutamate.

L-asparaginase (ASNase): Enzyme used therapeutically to deplete extracellular asparagine by hydrolysing it into aspartate and ammonia.

Amino acid exchange factor: A metabolite that facilitates the reciprocal transport of intracellular and extracellular amino acids across the cell membrane.

Mechanistic target of rapamycin complex 1 (mTORC1): A central kinase complex that senses nutrient levels to regulate cell growth and protein synthesis.

Nuclear factor erythroid 2-related factor 2 (NRF2): A transcription factor that orchestrates cellular antioxidant and stress responses.

Tumour microenvironment: The surrounding stromal, immune and extracellular matrix components that interact metabolically and signalling-wise with cancer cells.

References

1. Asparagine restriction enhances CD8+ T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response. Nature Metabolism (2023).
2. Extracellular Vesicle‐Packaged Linc‐ZNF25‐1 from Pancreatic Cancer Cell Promotes Pancreatic Stellate Cell Uptake of Asparagine to Advance Chemoresistance. Advanced Science (2025).
3. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nature Communications (2016).
4. Asparagine: A Metabolite to Be Targeted in Cancers. Metabolites (2021).
5. SOX12 promotes colorectal cancer cell proliferation and metastasis by regulating asparagine synthesis. Cell Death & Disease (2019).